The Latest: US regulators allow remdesivir for hospitalized
|
August 28, 2020 3:27 PM
FOSTER CITY, California — U.S. regulators are now allowing use of experimental antiviral drug remdesivir for all patients hospitalized with COVID-19, drugmaker Gilead Sciences said Friday.
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
